Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-19

Clinical Trial Update: Ketoconazole Contributes to Cryptorchidism Outcome Via Modulating Macrophage Trem2 [NA]

View source ↗

Summary

The clinical trial update reports that ketoconazole may influence outcomes in cryptorchidism by modulating macrophage Trem2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketoconazole (Ketoconazole)

Snippet

Sponsor: Affiliated Hospital of Nantong University | Conditions: Cryptorchidism | NA | Status: UNKNOWN